コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ., amino acids) and bacterial stimuli (e.g., Helicobacter pylori).
2 bacteria such as the human gastric pathogen Helicobacter pylori.
3 dy the epithelial response to infection with Helicobacter pylori.
4 main protein from the human gastric pathogen Helicobacter pylori.
5 uman papilloma virus, hepatitis C virus, and Helicobacter pylori.
6 was described as a chemotaxis attractant for Helicobacter pylori.
7 ence factor secreted by the gastric pathogen Helicobacter pylori.
8 uman papilloma virus, hepatitis C virus, and Helicobacter pylori.
9 se is infection by a gram-negative bacterium Helicobacter pylori.
10 s associated with tetracycline resistance in Helicobacter pylori.
11 tion also occurs in a homologous operon from Helicobacter pylori.
12 infection with the human bacterial pathogen Helicobacter pylori.
13 demic and epidemic typhus, trench fever, and Helicobacter pylori.
14 cytotoxin-associated gene A (CagA)-positive Helicobacter pylori.
15 el (Ni) is critical for the pathogenicity of Helicobacter pylori.
16 t ranges, such as the human stomach pathogen Helicobacter pylori.
17 i, Shigella sonnei, Campylobacter jejuni and Helicobacter pylori.
18 at infections caused by the gastric pathogen Helicobacter pylori.
19 nfection with the gastric bacterial pathogen Helicobacter pylori.
20 rgy and infection with the gastric bacterium Helicobacter pylori.
21 ainst SK from Mycobacterium tuberculosis and Helicobacter pylori.
22 s has been questioned since the discovery of helicobacter pylori.
23 hout rejection (group D: acute enteritis, 9; Helicobacter pylori, 1; Streptococcal pharyngitis 1; and
24 rophage EGFR signaling during infection with Helicobacter pylori, a bacterial pathogen that causes pe
26 Although all individuals were infected with Helicobacter pylori, abnormal expression of alpha(1,2)fu
28 l. (2016) perform structural analyses of the Helicobacter pylori adhesin BabA to determine how the ba
29 crophages mediate the epithelial response to Helicobacter pylori and are involved in the development
31 ator of M1 macrophage activation during both Helicobacter pylori and Citrobacter rodentium infection.
32 ce were infected with Helicobacter felis and Helicobacter pylori and compared with noninfected animal
36 model explicitly incorporated the impact of Helicobacter pylori and smoking on disease natural histo
37 -d-cholesteryl glucopyranoside (alphaCAG) of Helicobacter pylori and the corresponding galactose anal
39 cquired infections, clarithromycin-resistant Helicobacter pylori, and fluoroquinolone-resistant Campy
40 ng for celiac disease, autoimmune gastritis, Helicobacter pylori, and hereditary forms of IDA is reco
41 forces do, however, appear to play a role in Helicobacter pylori, and some individual genes in all gr
42 enocarcinoma and seropositivity to different Helicobacter pylori antigens using multiplex serology ha
44 We explore the role of aconitase (AcnB) in Helicobacter pylori as a posttranscriptional regulator o
45 Previous characterization of the analogous Helicobacter pylori Asn-transamidosome revealed that it
46 as being involved in the pathophysiology of Helicobacter pylori-associated diseases, the role of oth
47 n chronic inflammatory conditions, including Helicobacter pylori-associated gastritis, where its prod
48 that shares similarities to the etiology of Helicobacter pylori-associated intestinal-type gastric a
50 ce of this coincides with the eradication of Helicobacter pylori, both of which might alter the oesop
51 tors for the gram negative gastric bacterium Helicobacter pylori but only for a few this has unequivo
52 e, ghrelin, adiponectin and the influence of Helicobacter pylori, but also brings into light new proc
53 e in the evolution of the bacterial pathogen Helicobacter pylori, but its dynamics remain incompletel
54 tantly related species Bacillus subtilis and Helicobacter pylori, but its role in bacterial chemotaxi
57 ation of particular polymorphisms within the Helicobacter pylori CagL hypervariable motif (CagLHM) in
58 (Mycoplasma pneumoniae, Treponema pallidum, Helicobacter pylori, Campylobacter jejuni, Synechocystis
59 ave recently found that the gastric pathogen Helicobacter pylori can activate gastric stem cells and
60 : Despite inducing an inflammatory response, Helicobacter pylori can persist in the gastric mucosa fo
63 nization with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes inf
65 ld's population is chronically infected with Helicobacter pylori, causing gastritis, gastric ulcers a
68 monas vaginalis, and the bacterial pathogens Helicobacter pylori, Clostridium difficile, and Bacteroi
80 use and this can be treated empirically with Helicobacter pylori eradication therapy in those that ar
82 to the HobA-interacting surface of DnaA from Helicobacter pylori even though HobA is an activator of
86 antified the expression of a large number of Helicobacter pylori genes and found high expression of g
89 reened, for the first time to our knowledge, Helicobacter pylori GML-associated strains for their cap
94 er mortality due to therapy resistance, with Helicobacter pylori (H. pylori) infection being a major
97 known to have an extremely low prevalence of Helicobacter pylori (H. pylori) infection, with the hypo
103 cal studies indicated that colonization with Helicobacter pylori (H. pylori) may affect body mass ind
104 -proliferation was reported in patients with Helicobacter pylori (H. pylori)-infected gastric mucosa
106 r's disease, primary open-angle glaucoma and Helicobacter pylori (H.pylori) infection in all possible
107 f of the world's population is infected with Helicobacter pylori (H.pylori), a bacterium shown to be
108 helical shape of the human stomach pathogen Helicobacter pylori has been suggested to provide mechan
112 ges that occur during chronic infection with Helicobacter pylori have been analysed, but little is kn
114 s like HIV, respiratory syncytial virus, and Helicobacter pylori; however, none of these products has
116 explorative study evaluates the efficacy of Helicobacter pylori (HP) eradication (HPE) therapy on ea
123 bination of serum pepsinogens(PGs), IgG anti-Helicobacter pylori (HpAb), and osteopontin (OPN) can be
125 acterized the binding of parS and Spo0J from Helicobacter pylori (HpSpo0J) and solved the crystal str
126 , in some cases such as the gastric pathogen Helicobacter pylori, HtrA is secreted where it cleaves t
127 o investigate the frequency of cagA-positive Helicobacter pylori in Mexican patients with gastric pat
135 , gastric immunopathology was accelerated in Helicobacter pylori-infected Gkn2 knockout mice and was
136 proposed that the accompanying microbiota in Helicobacter pylori-infected individuals might affect di
138 y, small intestinal bacterial overgrowth and Helicobacter pylori infection affect motor fluctuations
139 Current guidelines recommend testing for Helicobacter pylori infection among users of low-dose as
142 icting data regarding an association between Helicobacter pylori infection and iron deficiency anemia
143 lial cells (GECs) are the primary target for Helicobacter pylori infection and may act as APCs regula
149 cing identified more IM patients with active Helicobacter pylori infection compared with histopatholo
152 ence from developed countries indicates that Helicobacter pylori infection correlates with a reduced
156 5 Ser-536 phosphorylation also occurs during Helicobacter pylori infection in macrophages and gastric
175 of gastric epithelial cells is a hallmark of Helicobacter pylori infection, and altered epithelial ce
176 ce of peptic ulcers, strategies to eradicate Helicobacter pylori infection, and prophylaxis against u
177 egulation of iNOS has been observed in human Helicobacter pylori infection, but the cellular sources
178 with Helicobacter felis to create a model of Helicobacter pylori infection--the most common human chr
182 c adenocarcinoma is strongly associated with Helicobacter pylori infection; however, most infected pe
183 ication rates of standard triple therapy for Helicobacter pylori infections have decreased in recent
192 Furthermore, we quantify the invasion of Helicobacter pylori into the glands of the mouse stomach
205 c infection with the Gram-negative bacterium Helicobacter pylori is a major risk factor for the devel
206 stent colonization of the human stomach with Helicobacter pylori is a risk factor for gastric adenoca
211 ytotoxin associated gene A (CagA) protein of Helicobacter pylori is associated with increased virulen
213 emotaxis receptor mRNA of the human pathogen Helicobacter pylori is directly targeted by a small RNA
218 of diseases elicited by the gastric pathogen Helicobacter pylori is partially determined by the effec
223 Infection with the gram-negative bacterium Helicobacter pylori is the most prevalent chronic bacter
228 nfection with the gastric bacterial pathogen Helicobacter pylori is typically contracted in early chi
229 nic atrophic gastritis due to infection with Helicobacter pylori; it might be a precursor to intestin
231 % of the world's population is infected with Helicobacter pylori, leading to chronic inflammation, wh
232 tructure of a soluble variant of full-length Helicobacter pylori MotB in which the plug helix was eng
240 omavirus, herpes virus) and bacterial (e.g., Helicobacter pylori, pneumonia) diseases, and autoimmune
241 link is provided by the association between Helicobacter pylori-positive gastritis and gastric MALT
242 re commonly used as a first-line therapy for Helicobacter pylori-positive patients; however, resistan
244 PCs) frequently occurs during infection with Helicobacter pylori, predisposing patients to cancer.
246 panel to assess whether seropositivity to 15 Helicobacter pylori proteins was associated with subsequ
247 mologs from Campylobacter coli (R.CcoLI) and Helicobacter pylori (R.HpyAXII) and demonstrated their D
250 s, including norovirus, Campylobacter fetus, Helicobacter pylori, Salmonella enterica, and Giardia la
252 , P = .13); 20.0% of the cohort had positive Helicobacter pylori serology (16 vs 2 in the CG, P = .00
258 ogical and molecular features including age, Helicobacter pylori status, tumor site, patient survival
265 and gastric cancer are caused most often by Helicobacter pylori strains that harbor the cag pathogen
269 nd showed that it plays an important role in Helicobacter pylori stress tolerance and survival in the
275 cronutrients modulate gene expression within Helicobacter pylori, the strongest identified risk facto
276 tic distribution of human pathogens, such as Helicobacter pylori, thereby demonstrating the potential
278 bA adhesin mediates high-affinity binding of Helicobacter pylori to the ABO blood group antigen-glyco
295 of galectin-3 (Gal3) in gastric infection by Helicobacter pylori We first demonstrated that Gal3 was
296 been associated with chronic infection with Helicobacter pylori; we investigated the bacteria's pote
297 ory p53 isoforms by the pathogenic bacterium Helicobacter pylori, which is known for its strong assoc
298 oteins in the bacterial chemotaxis system of Helicobacter pylori, which requires two nonredundant cou
300 we present two high-resolution structures of Helicobacter pylori XerH with its recombination site DNA
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。